Avion Wealth’s Arcus Biosciences RCUS Stock Holding History

Avion Wealth’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Hold	64	–	–	﹤0.01%	1119
2025 Q4	$1K	Hold	64	–	–	﹤0.01%	1115
2025 Q3	$0	Hold	64	–	–	﹤0.01%	1487
2025 Q2	$0	Buy	+64	New	+$547	﹤0.01%	1532

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Avion Wealth's RCUS Position: Q1 2026 in Review

Avion Wealth held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 64 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1119.

Avion Wealth first reported a position in RCUS in Q2 2025 and has held it in 4 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

Avion Wealth held 64 shares of Arcus Biosciences worth $1K as of Q1 2026.
Avion Wealth left its Arcus Biosciences share count unchanged in Q1 2026.
Arcus Biosciences made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1119 holding.
Avion Wealth first reported a position in Arcus Biosciences in Q2 2025 and has held it in 4 quarters since.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.